Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?

Sepideh Mirzaei; Mahshid Deldar Abad Paskeh; Yalda Saghari; Ali Zarrabi; Michael R Hamblin; Maliheh Entezari; Mehrdad Hashemi; Amir Reza Aref; Kiavash Hushmandi; Alan Prem Kumar; Navid Rabiee; Milad Ashrafizadeh; Saeed Samarghandian

doi:10.1016/j.ijbiomac.2022.02.094

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2008

The absence of latent transforming growth factor-beta binding protein–1 (LTBP–1) inhibits TGF-beta secretion

F Drews, Chester H. Conrad, AM Gressner, Ralf Weiskirchen

Article2007

Disruption of the latent transforming growth factor-β binding protein-1 gene causes alteration in facial structure and influences TGF-β bioavailability

F Drews, Sebastian Knöbel, Markus Moser, Kai Gerrit Muhlack, S Mohren, Christian Stoll, Andreas Bosio, Axel M. Gressner, Ralf Weiskirchen

Article2018

M7824 (MSB0011359C), a bifunctional fusion protein targeting transforming growth factor β (TGF-β) and PD-L1, in Asian patients with pretreated biliary tract cancer (BTC): Efficacy by BTC subtype

Changhoon Yoo, Do‐Youn Oh, Hye Jin Choi, Masatoshi Kudo, Makoto Ueno, Shunsuke Kondo, L.-T. Chen, Mitsumasa Osada, Christoph Helwig, Isabelle Dussault, Masafumi Ikeda

Article2000

Transforming growth factor-β 1 inhibits β 2 -adrenoceptor gene transcription

Jcw Mak, Jonathan Rousell, El‐Bdaoui Haddad, Peter J Barnes

Article2014

Immunomodulatory effects of transforming growth factor-β in the liver.

Hans-Theo Schon, Ralf Weiskirchen